GL1X · GenesisL1 explorer

MolNFT v1 · #103726 · protein

Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RAFV600E kinase

4PP7 · SERINE/THREONINE-protein kinase B-RAF: “Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RAFV600E kinase”. X-ray diffraction, 1 ligand (2VX), 6 pockets (best druggability 0.75). MolNFT v1 #103726 on…

PDB
4PP7
Type
protein
Length
541 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase B-RAF
EC
2.7.11.1
UniProt
P15056
Ligands
2VX
Pockets
6 · best druggability 0.75

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase B-RAF (EC 2.7.11.1)protein26740% helix, 13% strandP15056
BSERINE/THREONINE-protein kinase B-RAF (EC 2.7.11.1)protein27438% helix, 15% strandP15056

Ligands and binding sites

  • 2VX · N-{2,4-difluoro-3-[methyl(3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino]phenyl}propane-1-sulfonamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15910.750.82682VX
25410.730.81482VX
31460.630.8529empty
41790.550.8021empty
51540.510.7922empty

Interfaces

1 interface between chains.

  • A–B · 1149 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4PP7 · Highly Potent and Selective 3-N-methylquinazoline-4(3H)-one Based Inhibitors of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P15056 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase B-RAF (P15056) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.